BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30623686)

  • 1. Postmenopausal androgen-secreting ovarian tumors: challenging differential diagnosis in two cases.
    Arteaga E; Martinez A; Jaramilo J; Villaseca P; Cuello M; Valenzuela P; Gejman R; Blumel JE
    Climacteric; 2019 Aug; 22(4):324-328. PubMed ID: 30623686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.
    Chen M; Zhou W; Zhang Z; Zou Y; Li C
    Medicine (Baltimore); 2018 Mar; 97(10):e0093. PubMed ID: 29517680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperandrogenism due to a testosterone-secreting Sertoli-Leydig cell tumor associated with a dehydroepiandrosterone sulfate-secreting adrenal adenoma in a postmenopausal woman: case presentation and review of literature.
    Herrera JD; Davidson JA; Mestman JH
    Endocr Pract; 2009 Mar; 15(2):149-52. PubMed ID: 19289327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic pitfalls in ovarian androgen-secreting (Leydig cell) tumours: case series.
    Fanta M; Fischerová D; Indrielle-Kelly T; Koliba P; Zdeňková A; Burgetová A; Vrbíková J
    J Obstet Gynaecol; 2019 Apr; 39(3):359-364. PubMed ID: 30428740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian Leydig Cell Tumor and Ovarian Hyperthecosis in a Postmenopausal Woman: A Case Report and Literature Review.
    Bužinskienė D; Marčiukaitytė R; Šidlovska E; Rudaitis V
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
    Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
    Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leydig cell tumour and mature ovarian teratoma: rare androgen-secreting ovarian tumours in postmenopausal women.
    Palha A; Cortez L; Tavares AP; Agapito A
    BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27803082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of selective venous catheterization in localizing a small androgen-producing tumor in ovary.
    Nishiyama S; Hirota Y; Udagawa Y; Kato R; Hayakawa N; Tukada K
    Med Sci Monit; 2008 Feb; 14(2):CS9-12. PubMed ID: 18227769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Androgenic alopecia revealing an androgen secreting ovarian tumor].
    Roux-Guinot S; Gorin I; Vadrot D; Djid R; Bethoux JP; Escande JP
    Ann Dermatol Venereol; 2001 Nov; 128(11):1241-4. PubMed ID: 11908171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral Leydig cell tumour of the ovary: a rare cause of virilization in postmenopausal patient.
    Sanz OA; Martinez PR; Guarch RT; Goñi MJ; Alcazar JL
    Maturitas; 2007 Jun; 57(2):214-6. PubMed ID: 17289310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
    Cserepes E; Szücs N; Patkós P; Csapó Z; Molnár F; Tóth M; Dabasi G; Esik O; Rácz K
    Gynecol Endocrinol; 2002 Jun; 16(3):213-6. PubMed ID: 12192893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases.
    Hofland M; Cosyns S; De Sutter P; Bourgain C; Velkeniers B
    Gynecol Endocrinol; 2013 Mar; 29(3):213-5. PubMed ID: 22835278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult symptomatic bilateral pure Leydig cell tumors in a postmenopausal woman: a case report.
    Hussain SA; Dubil EA; De Luca-Johnson JN; Johnston M
    Gynecol Endocrinol; 2021 Jul; 37(7):672-675. PubMed ID: 34137345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral virilizing hilus (Leydig) cell tumors of the ovary.
    Duun S
    Acta Obstet Gynecol Scand; 1994 Jan; 73(1):76-7. PubMed ID: 8304034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of clinical, hormonal, radiological, and immunohistochemical studies on the diagnosis of postmenopausal hyperandrogenism.
    Sarfati J; Bachelot A; Coussieu C; Meduri G; Touraine P;
    Eur J Endocrinol; 2011 Nov; 165(5):779-88. PubMed ID: 21896622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal hyperandrogenism.
    Yoldemir T
    Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperandrogenism in post-menopausal women: a diagnosis challenge.
    Tutzer M; Winnykamien I; Davila Guardia J; Castelo-Branco C
    Gynecol Endocrinol; 2014 Jan; 30(1):23-5. PubMed ID: 24188447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
    Waggoner W; Boots LR; Azziz R
    Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low leptin level in an obese hyperandrogenic woman--potential marker for androgen-secreting tumor.
    Cvijovic G; Yamashita SA; Micic D; Kendereski A; Sumarac-Dumanovic M; Zoric S; Popovic V
    Gynecol Endocrinol; 2007 Feb; 23(2):112-6. PubMed ID: 17454162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal androgen secreting ovarian tumour: pathophysiological implications; a case report.
    Pérez A; Calaf J; Webb SM; Prat J; de Leiva A
    Eur J Obstet Gynecol Reprod Biol; 1990 Apr; 35(1):97-105. PubMed ID: 2107106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.